ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Vincerx Inc

Vincerx Inc (VINC)

0.335
-0.0044
( -1.30% )
Updated: 02:00:09

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.335
Bid
0.335
Offer
0.34
Volume
5,975
0.3315 Day's Range 0.3394
0.3161 52 Week Range 9.3722
Market Cap
Previous Close
0.3394
Open
0.3394
Last Trade
74
@
0.335
Last Trade Time
01:57:44
Financial Volume
US$ 2,025
VWAP
0.338943
Average Volume (3m)
537,292
Shares Outstanding
29,671,903
Dividend Yield
-
PE Ratio
-14.04
Earnings Per Share (EPS)
-1.35
Revenue
-
Net Profit
-40.16M

About Vincerx Inc

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2021
Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was US$0.34. Over the last year, Vincerx shares have traded in a share price range of US$ 0.3161 to US$ 9.3722.

Vincerx currently has 29,671,903 shares in issue. The market capitalisation of Vincerx is US$10.07 million. Vincerx has a price to earnings ratio (PE ratio) of -14.04.

VINC Latest News

Vincerx Pharma Reports Third Quarter 2024 Financial Results

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data expected by early 2025 Completed Phase 1...

Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates

VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the programโ€™s potential and validating the VersAptxโ„ข...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0042-1.238207547170.33920.380.31614473220.33242827CS
4-0.0449-11.81889971050.37990.40980.31613617120.35858765CS
12-0.4139-55.26772599810.74890.850.31615372920.50415647CS
26-0.472-58.4882280050.8070.85860.31613491060.55710735CS
52-0.5375-61.60458452720.87259.37220.31616102511.91447468CS
156-13.495-97.577729573413.8313.830.31612853212.05190414CS
260-19.785-98.334990059620.1226.750.31612458283.55282966CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MVSTMicrovast Holdings Inc
US$ 0.588919
(225.91%)
283.48M
BTCTBTC Digital Ltd
US$ 21.36
(103.43%)
15.92M
KXINKaixin Holdings
US$ 4.934
(68.97%)
27.48M
BTCSBTCS Inc
US$ 4.75
(64.93%)
29.1M
DAVEDave Inc
US$ 89.25
(42.12%)
891.88k
SYRSSyros Pharmaceuticals Inc
US$ 0.38
(-86.08%)
19.79M
GCTKGlucoTrack Inc
US$ 0.375
(-76.11%)
2.09M
PETWag Group Company
US$ 0.2756
(-57.98%)
1.13M
VINOGaucho Group Holdings Inc
US$ 2.065
(-53.60%)
58.14k
SIDUSidus Space Inc
US$ 1.26
(-44.00%)
2.26M
MVSTMicrovast Holdings Inc
US$ 0.588919
(225.91%)
272.43M
AGRIAgriFORCE Growing Systems Ltd
US$ 0.0476
(0.42%)
163.38M
NMHINatures Miracle Holding Inc
US$ 0.1109
(29.40%)
125.36M
ELABElevai Labs Inc
US$ 0.0192
(2.13%)
103.91M
RIVNRivian Automotive Inc
US$ 12.68
(19.85%)
36.6M

VINC Discussion

View Posts
tw0122 tw0122 1 month ago
VINC .84 + 20% โ€ฆ05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +
๐Ÿ‘๏ธ0
Laster Laster 7 months ago
What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Canโ€™t believe they didnโ€™t try to do the financing when it was trading above $5.
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Tomorrow will be $1.50
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Blood bath. I should have waited one more day.
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
Somebody knows something you donโ€™t
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
I donโ€™t find the price and volume the capital raise is. Am I missing anything here?
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
Check for SEC filings
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Is the capital raise 80% discounted to yesterday price? Insane
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
Check for a capital raise which means dilution
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Wonder why there is a steep fall in price when the results are not negative.
๐Ÿ‘๏ธ0
RAlbert RAlbert 7 months ago
Wonder why there is a steep fall in price when the results are not negative.
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
VINC 10Q due 4/3
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC new 52.week hi
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC new 52 week high
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC in the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Tom turtles Tom turtles 8 months ago
Very nice surprise...🆙⬆️
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
VINC new 52 week high
๐Ÿ‘๏ธ0
glenn1919 glenn1919 9 months ago
VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Awl416 Awl416 9 months ago
160k wall getting gobbled up
๐Ÿ‘๏ธ0
Awl416 Awl416 9 months ago
Another leg. Damn
๐Ÿ‘๏ธ0
Awl416 Awl416 9 months ago
Whoโ€™s poking it?
๐Ÿ‘๏ธ0
Monksdream Monksdream 9 months ago
VINC under $2
๐Ÿ‘๏ธ0
make it happen make it happen 10 months ago
It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.
๐Ÿ‘๏ธ0
alchemytrader alchemytrader 10 months ago
moving...
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
VINC under $2
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock